IRCT20230222057495N11招募中Unknown
Bioequivalence study of phenazopyridine hydrochloride 100 mg tablets of Mehr Darou pharmaceutical company compared to the phenazopyridine hydrochloride 100 mg sample of Pfizer in Germany on healthy volunteers.
Mehr Darou Pharmaceutical Company0 个研究点目标入组 24 人开始时间: 待定最近更新:
适应症
试验速览
- 阶段
- Unknown
- 状态
- 招募中
- 发起方
- 入组人数
- 24
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 18 years 至 55 years（—）
- 性别
- All
入选标准
- •Healthy volunteer between 18 and 55 years old.
- •Body mass index less than 30 kg per square meter.
- •All candidates must be non-smokers.
排除标准
- •Blood pressure less than 90 on 60 mm Hg or more than 140 on 90 mm Hg
- •Consumption of any drug, alcohol or tobacco within 2 weeks before receiving the drug
研究者
相似试验
尚未招募
Unknown
Bioequivalence study of Phenazopyridine 100mg tabletThis study is performed on healthy volunteers..IRCT20200623047902N31Ronak Pharm company24
招募中
Unknown
Bioequivalence study of methylphenidate hydrochloride 10 mg tabletIRCT20230222057495N15Jalinous Pharmaceutical Company24
尚未招募
Unknown
Comparative in vivo evaluation of 2 Hydrochlorothiazide 50 mg Tablet formulations.IRCT20180620040164N51Karen Pharma and Food Supplement Co.24
招募中
Unknown
In vivo Bioequivalence study of Hydrochlorothiazide tabletIRCT20220211053992N21Tabriz University of Medical Sciences24
招募中
Unknown
Investigating bioequivalence of Pentoprazole capsuleIn the present study, the products will be administered to healthy volunteers..IRCT20220211053992N14Tabriz University of Medical Sciences24